Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
Date:2/24/2009

Dial: 800.561.2718 (U.S.); 617.614.3525 (international) Participant Passcode: 32041145 (Howard Robin is the host)

An audio replay will also be available shortly after the call and will remain so through March 16, 2009.

        To access the replay, follow these instructions:
        Dial: 888-286-8010 (U.S.); 617-801-6888 (international)
        Participant Passcode: 44161634

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugate technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own high-value therapeutics that addresses unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. For more information on Nektar Therapeutics, please visit http://www.nektar.com.

This press release contains forward-looking statements that reflect the company's current views regarding the potential of the company's pipeline of proprietary drug candidates, the value and potential of the company's technology, and the company's financial position. These forward-looking statements involve numerous risks and uncertainties, including but not limited to: (i) the company's proprietary product candidates and those of its collaboration partners are in various stages of clinical development and the risk of failure is high and can unexpectedly occur at any stage of development prior to regulatory approval for numerous reasons including safety and efficacy findings; (ii) the timing or success of the commencement or end of clinical trials and commercial launch of partnered products may be delayed or unsuccessful due to slower th
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
2. Nektar Announces Retirement of Irwin Lerner from Board of Directors
3. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
4. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
5. Nektar Therapeutics to Webcast R&D Day on November 12th
6. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
7. Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City
9. Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets
10. Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
11. Nektars PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Researchers from the Southern University of Denmark ... and the acne causing P.acnes bacteria. Researchers believe found that ... out oxygen deprived location to seek shelter and grow. When ... the ability to live in the open joint areas, causing ... “ The best acne treatment ” explains why starting a ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 The ... announced the appointment of Lisa Baird as Executive Director. ... July 8, 2013. The WMIS vision is ... applications to understand and effectively treat diseases in the ... Society (WMIS) was established in 2011 by integrating the ...
(Date:5/17/2013)... Oven Industries Inc. announces a new temperature ... has many user-friendly benefits. Contained all in one enclosure, ... a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... universally, which allows the user to use the device ...
(Date:5/17/2013)... N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability ,     New facility ... pressures , Syngenta unveiled its ... today at the company’s RTP Innovation Center. The first ... company researchers to simulate any agricultural climate and precisely ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2WMIS Appoints Lisa Baird as Next Executive Director 2New Temperature Control Products Announced by Oven Industries Inc. 2Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... leader will provide commercialization expertise to company, ... Inc., a company,revolutionizing spine care through the development ... William L. Lister as the,newest member of the ... board,s,Compensation Committee and will focus on guiding the ...
... Calif., Oct. 14 Clontech Laboratories,Inc., a wholly-owned ... of the 2008 Nobel Prize in Chemistry; Drs. ... the discovery and development of the green,fluorescent protein ... proteins.,The application of fluorescent proteins as a research ...
... 14 Sysmex America, Inc. and its,subsidiary Sysmex ... system product offering from MOLIS WAM to Sysmex ... the company,s new Sysmex brand,architecture., "Sysmex WAM ... our strong,position in the hematology automation systems market ...
Cached Biology Technology:Axial Biotech Appoints Retired Roche Diagnostics Executive to Board 2Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry 2
(Date:5/17/2013)... China---- Why Tibetan antelope can live at elevations ... collaborative research published in Nature Communications , ... provide evidence that some genetic factors may be ... environments. The data in this work will also ... the biology of other ruminant species. , The ...
(Date:5/17/2013)... An international team of scientists using a new X-ray ... a living frog embryo in greater detail than ever ... biological research and the search for new treatments for ... Institut fr Technologie in Germany, in collaboration with the ... Argonne National Laboratory, released the most precise depiction ever ...
(Date:5/16/2013)... to a fast food restaurant had a higher body ... from fast food, according to researchers at The University ... was particularly strong among those with a lower income. ... American Journal of Public Health indicates higher ... restaurant, and among lower-income African-Americans, the density, or number, ...
Breaking Biology News(10 mins):The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... Security: From Local to Global, will be the focus ... but this single event is just one small step ... priority around the world and requires immediate attention in ... hunger and deficiencies. The Society for Nutrition Education (SNE) ...
... a little gooey, but it,s not turning mums, brains into ... University. The study conducted by the Centre for ... fears mothers may have that pregnancy affects their cognitive functions, ... findings have been released as part of Mental Health Week, ...
... Synaptics(R),Incorporated (Nasdaq: SYNA ), a leading ... and entertainment devices,announced today that it will report ... on Thursday, October 23, 2008 after the close ... call for analysts and,investors at 2:00 p.m. PT ...
Cached Biology News:World Food Day brings attention to food security around the globe 2Pregnancy not turning minds to mush: Study 2Synaptics to Report First Quarter Results on October 23 2
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
... G. Butcher (1998). • The major histocompatibility ... in the immunology area. There is great ... and in their function as antigen-presenting molecules. ... the prospect of tackling biochemical and genetic ...
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
Biology Products: